Pharmacokinetic validation of neoral absorption profiling
- 15 May 2000
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 32 (3), S53-S56
- https://doi.org/10.1016/s0041-1345(00)00864-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1Transplantation, 1999
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- PEAK CYCLOSPORINE LEVELS (Cmax) CORRELATE WITH FREEDOM FROM LIVER GRAFT REJECTIONTransplantation, 1999
- Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral sandimmune to neoralClinical Therapeutics, 1999
- Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 yearTransplantation Proceedings, 1998
- Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survivalTransplantation Proceedings, 1997
- Predicting patients' exposure to cyclosporinTransplant International, 1996
- REDUCED INTER- AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A MICROEMULSION FORMULATION IN CONJUNCTION WITH FASTING, LOW-FAT MEALS, OR HIGH-FAT MEALS1,2Transplantation, 1995
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993